309 related articles for article (PubMed ID: 26439382)
1. Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer's Disease-Causing Mutants in Presenilins.
Mak DO; Cheung KH; Toglia P; Foskett JK; Ullah G
PLoS Comput Biol; 2015 Oct; 11(10):e1004529. PubMed ID: 26439382
[TBL] [Abstract][Full Text] [Related]
2. The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore.
Toglia P; Ullah G
Cell Calcium; 2016 Jul; 60(1):13-24. PubMed ID: 27184076
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.
Cheung KH; Mei L; Mak DO; Hayashi I; Iwatsubo T; Kang DE; Foskett JK
Sci Signal; 2010 Mar; 3(114):ra22. PubMed ID: 20332427
[TBL] [Abstract][Full Text] [Related]
4. Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca(2+) disruptions.
Toglia P; Cheung KH; Mak DO; Ullah G
Cell Calcium; 2016 May; 59(5):240-50. PubMed ID: 26971122
[TBL] [Abstract][Full Text] [Related]
5. A kinetic model of single and clustered IP3 receptors in the absence of Ca2+ feedback.
Shuai J; Pearson JE; Foskett JK; Mak DO; Parker I
Biophys J; 2007 Aug; 93(4):1151-62. PubMed ID: 17526578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gating dynamics of different IP
Cai X; Li X; Qi H; Wei F; Chen J; Shuai J
Phys Biol; 2016 Oct; 13(5):056005. PubMed ID: 27749281
[TBL] [Abstract][Full Text] [Related]
7. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.
Alzayady KJ; Wagner LE; Chandrasekhar R; Monteagudo A; Godiska R; Tall GG; Joseph SK; Yule DI
J Biol Chem; 2013 Oct; 288(41):29772-84. PubMed ID: 23955339
[TBL] [Abstract][Full Text] [Related]
8. Time to blip--stochastic simulation of single channel opening.
Thul R
Cold Spring Harb Protoc; 2014 May; 2014(5):. PubMed ID: 24786499
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.
Cheung KH; Shineman D; Müller M; Cárdenas C; Mei L; Yang J; Tomita T; Iwatsubo T; Lee VM; Foskett JK
Neuron; 2008 Jun; 58(6):871-83. PubMed ID: 18579078
[TBL] [Abstract][Full Text] [Related]
10. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
[TBL] [Abstract][Full Text] [Related]
11. Analyzing optical imaging of Ca
Toglia P; Ullah G; Pearson JE
Cell Calcium; 2017 Nov; 67():65-73. PubMed ID: 29029792
[TBL] [Abstract][Full Text] [Related]
12. Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function.
Terry LE; Alzayady KJ; Wahl AM; Malik S; Yule DI
J Biol Chem; 2020 Dec; 295(52):18160-18178. PubMed ID: 33093175
[TBL] [Abstract][Full Text] [Related]
13. Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling.
Müller M; Cheung KH; Foskett JK
Antioxid Redox Signal; 2011 Apr; 14(7):1225-35. PubMed ID: 20701429
[TBL] [Abstract][Full Text] [Related]
14. Modeling local and global intracellular calcium responses mediated by diffusely distributed inositol 1,4,5-trisphosphate receptors.
Williams GS; Molinelli EJ; Smith GD
J Theor Biol; 2008 Jul; 253(1):170-88. PubMed ID: 18405920
[TBL] [Abstract][Full Text] [Related]
15. IP3 receptors: Take four IP3 to open.
Taylor CW; Konieczny V
Sci Signal; 2016 Apr; 9(422):pe1. PubMed ID: 27048564
[TBL] [Abstract][Full Text] [Related]
16. Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
Müller M; Cárdenas C; Mei L; Cheung KH; Foskett JK
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13293-8. PubMed ID: 21784978
[TBL] [Abstract][Full Text] [Related]
17. IP
Hamada K; Miyatake H; Terauchi A; Mikoshiba K
Proc Natl Acad Sci U S A; 2017 May; 114(18):4661-4666. PubMed ID: 28416699
[TBL] [Abstract][Full Text] [Related]
18. Comparison of and chromogranin effect on inositol 1,4,5-trisphosphate sensitivity of cytoplasmic and nucleoplasmic inositol 1,4,5-trisphosphate receptor/Ca2+ channels.
Huh YH; Kim KD; Yoo SH
Biochemistry; 2007 Dec; 46(49):14032-43. PubMed ID: 17997581
[TBL] [Abstract][Full Text] [Related]
19. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
[TBL] [Abstract][Full Text] [Related]
20. Ligand sensitivity of type-1 inositol 1,4,5-trisphosphate receptor is enhanced by the D2594K mutation.
Tambeaux A; Aguilar-Sánchez Y; Santiago DJ; Mascitti M; DiNovo KM; Mejía-Alvarez R; Fill M; Wayne Chen SR; Ramos-Franco J
Pflugers Arch; 2023 May; 475(5):569-581. PubMed ID: 36881190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
